261 related articles for article (PubMed ID: 26232065)
1. An Epigenetic Mechanism of High Gdnf Transcription in Glioma Cells Revealed by Specific Sequence Methylation.
Zhang BL; Liu J; Lei Y; Xiong Y; Li H; Lin X; Yao RQ; Gao DS
Mol Neurobiol; 2016 Sep; 53(7):4352-62. PubMed ID: 26232065
[TBL] [Abstract][Full Text] [Related]
2. Crosstalk between DNA methylation and histone acetylation triggers GDNF high transcription in glioblastoma cells.
Zhang B; Gu X; Han X; Gao Q; Liu J; Guo T; Gao D
Clin Epigenetics; 2020 Mar; 12(1):47. PubMed ID: 32183903
[TBL] [Abstract][Full Text] [Related]
3. Changes in transcriptional factor binding capacity resulting from promoter region methylation induce aberrantly high GDNF expression in human glioma.
Yu ZQ; Zhang BL; Ren QX; Wang JC; Yu RT; Qu DW; Liu ZH; Xiong Y; Gao DS
Mol Neurobiol; 2013 Dec; 48(3):571-80. PubMed ID: 23606280
[TBL] [Abstract][Full Text] [Related]
4. Enhancer II-targeted dsRNA decreases GDNF expression via histone H3K9 trimethylation to inhibit glioblastoma progression.
Zhang B; Han X; Gao Q; Liu J; Li S; Zha W; Wang X; Guo X; Gao D
Brain Res Bull; 2021 Feb; 167():22-32. PubMed ID: 33278485
[TBL] [Abstract][Full Text] [Related]
5. Egr-1 and RNA POL II facilitate glioma cell GDNF transcription induced by histone hyperacetylation in promoter II.
Zhang BL; Guo TW; Gao LL; Ji GQ; Gu XH; Shao YQ; Yao RQ; Gao DS
Oncotarget; 2017 Jul; 8(28):45105-45116. PubMed ID: 28187447
[TBL] [Abstract][Full Text] [Related]
6. Egr-1 participates in abnormally high gdnf gene transcription mediated by histone hyperacetylation in glioma cells.
Zhang BL; Ni HB; Liu J; Lei Y; Li H; Xiong Y; Yao R; Yu ZQ; Gao DS
Biochim Biophys Acta; 2014 Nov; 1839(11):1161-9. PubMed ID: 25201174
[TBL] [Abstract][Full Text] [Related]
7. [The Mechanism Study on Histone Acetylation Activating Glioblastoma-derived Neurotrophic Factor Transcription].
Wang JC; Quan XY; Peng DT; Hu GC
Sichuan Da Xue Xue Bao Yi Xue Ban; 2019 Sep; 50(5):643-648. PubMed ID: 31762231
[TBL] [Abstract][Full Text] [Related]
8. Hyperacetylation of histone H3K9 involved in the promotion of abnormally high transcription of the gdnf gene in glioma cells.
Yu ZQ; Zhang BL; Ni HB; Liu ZH; Wang JC; Ren QX; Mo JB; Xiong Y; Yao RQ; Gao DS
Mol Neurobiol; 2014 Dec; 50(3):914-22. PubMed ID: 24619502
[TBL] [Abstract][Full Text] [Related]
9. The reversible effects of glial cell line-derived neurotrophic factor (GDNF) in the human brain.
Ayanlaja AA; Zhang B; Ji G; Gao Y; Wang J; Kanwore K; Gao D
Semin Cancer Biol; 2018 Dec; 53():212-222. PubMed ID: 30059726
[TBL] [Abstract][Full Text] [Related]
10. [Increased Egr-1 binding to promoter induced by histone hyperacetylation promotes gdnf gene transcription].
Li Z; Liu J; Lei Y; Ni H; Cai H; Zhang B
Nan Fang Yi Ke Da Xue Xue Bao; 2015 May; 35(5):697-701. PubMed ID: 26018265
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional alterations in glioma result primarily from DNA methylation-independent mechanisms.
Court F; Le Boiteux E; Fogli A; Müller-Barthélémy M; Vaurs-Barrière C; Chautard E; Pereira B; Biau J; Kemeny JL; Khalil T; Karayan-Tapon L; Verrelle P; Arnaud P
Genome Res; 2019 Oct; 29(10):1605-1621. PubMed ID: 31533980
[TBL] [Abstract][Full Text] [Related]
12. DNA methylation dependent silencing of the human glutamate transporter EAAT2 gene in glial cells.
Zschocke J; Allritz C; Engele J; Rein T
Glia; 2007 May; 55(7):663-74. PubMed ID: 17311293
[TBL] [Abstract][Full Text] [Related]
13. Role of ERCC1 promoter hypermethylation in drug resistance to cisplatin in human gliomas.
Chen HY; Shao CJ; Chen FR; Kwan AL; Chen ZP
Int J Cancer; 2010 Apr; 126(8):1944-1954. PubMed ID: 19626585
[TBL] [Abstract][Full Text] [Related]
14. Regulation of GluR2 promoter activity by neurotrophic factors via a neuron-restrictive silencer element.
Brené S; Messer C; Okado H; Hartley M; Heinemann SF; Nestler EJ
Eur J Neurosci; 2000 May; 12(5):1525-33. PubMed ID: 10792430
[TBL] [Abstract][Full Text] [Related]
15. DNA methylation level of promoter region of activating transcription factor 5 in glioma.
Hua XM; Wang J; Qian DM; Song JY; Chen H; Zhu XL; Zhou R; Zhao YD; Zhou XZ; Li L; Zhang L; Song XX; Wang B
J Zhejiang Univ Sci B; 2015 Sep; 16(9):757-62. PubMed ID: 26365117
[TBL] [Abstract][Full Text] [Related]
16. DNA methyltransferase-mediated transcriptional silencing in malignant glioma: a combined whole-genome microarray and promoter array analysis.
Foltz G; Yoon JG; Lee H; Ryken TC; Sibenaller Z; Ehrich M; Hood L; Madan A
Oncogene; 2009 Jul; 28(29):2667-77. PubMed ID: 19465937
[TBL] [Abstract][Full Text] [Related]
17. Impact on prognosis of the regional distribution of MGMT methylation with respect to the CpG island methylator phenotype and age in glioma patients.
Mur P; Rodríguez de Lope Á; Díaz-Crespo FJ; Hernández-Iglesias T; Ribalta T; Fiaño C; García JF; Rey JA; Mollejo M; Meléndez B
J Neurooncol; 2015 May; 122(3):441-50. PubMed ID: 25682093
[TBL] [Abstract][Full Text] [Related]
18. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
19. Specific regulation of rat glial cell line-derived neurotrophic factor gene expression by riluzole in C6 glioma cells.
Caumont AS; Octave JN; Hermans E
J Neurochem; 2006 Apr; 97(1):128-39. PubMed ID: 16524382
[TBL] [Abstract][Full Text] [Related]
20. Characterization of a promoter for the human glial cell line-derived neurotrophic factor gene.
Baecker PA; Lee WH; Verity AN; Eglen RM; Johnson RM
Brain Res Mol Brain Res; 1999 Jun; 69(2):209-22. PubMed ID: 10366742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
